Physician profile

Linda Jean Bouchard

Obstetrics & Gynecology · Manteca, CA

NPI 1275569352

$752.24

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$91.34

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $546.37 2019-2023 Da Vinci Surgical System
Hologic Sales and Service, LLC $50.93 2019-2023 Aptima
Aspira Women'S Health INC $34.76 2022-2023 Ova1
Organon LLC $34.24 2021-2022
Myovant Sciences INC. $26.26 2022
Sumitomo Pharma America, INC. $21.17 2023 Myfembree
Merck Sharp & Dohme LLC $15.25 2022
Mayne Pharma Commercial LLC $11.93 2023
Novo Nordisk INC $11.33 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Linda Jean Bouchard

$752.24

in general payments reported 2019-2025

Years
2019-2023
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/655692/linda-jean-bouchard

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.